2-substituted 4-, 5-, and 6-[(1E)-3-oxo-3-phenylprop-1-en-1-yl]pyridazin-3(2H)-ones and 2-substituted 4,5-bis[(1E)-3-oxo-3-phenylprop-1-en-1-yl]pyridazin-3(2H)-ones as potent platelet aggregation inhibitors:: Design, synthesis, and SAR studies

被引:13
作者
Meyers, Caroline [1 ]
Yanez, Matilde [2 ]
Elmaatougi, Abdelazlz [3 ]
Verhelst, Tom [1 ]
Coelho, Alberto [4 ]
Fraiz, Nuria [2 ]
Lemiere, Guy L. F. [1 ]
Garcia-Mera, Xerardo [3 ]
Laguna, Reyes [2 ]
Cano, Ernesto [2 ]
Maes, Bert U. W. [1 ]
Sotelo, Eddy [3 ,4 ]
机构
[1] Univ Antwerp, Dept Chem, B-2020 Antwerp, Belgium
[2] Univ Santiago Compostela, Fac Pharm, Dept Farmacol, Espana, Spain
[3] Univ Santiago Compostela, Fac Pharm, Dept Quim Organ, Espana, Spain
[4] Univ Santiago Compostela, IFI, Unidad Quim Combinatoria, Espana, Spain
关键词
platelets; pyridazinones; chalcones; antiplatelet agents;
D O I
10.1016/j.bmcl.2007.11.034
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A set of regioisomeric 2-substituted pyridazin-3(2H)-ones containing a 3-oxo-3-phenylprop-1-en-1-yl fragment at either position 4, 5 or 6 and 2-substituted pyridazin-3(2H)-ones containing the same fragment both at positions 4 and 5 have been synthesized and evaluated as antiplatelet agents. The study allows the identification of a new highly potent platelet aggregation inhibitor (4c). (c) 2007 Elsevier Ltd. All rights reserved.
引用
收藏
页码:793 / 797
页数:5
相关论文
共 44 条
[1]   INOTROPIC, VASODILATOR AND LOW KM, CAMP-SELECTIVE, CGMP-INHIBITED PHOSPHODIESTERASE (PDE III) INHIBITORY ACTIVITIES OF 4-ALPHA-METHYL-4,4-ALPHA-DIHYDRO-5H-INDENO[1,2-C]PYRIDAZIN-3(2H)-ONES AND 4-ALPHA-METHYL-4,4-ALPHA,5,6-TETRAHYDROBENZO[H]CINNOLIN-3(2H)-ONES [J].
BAKEWELL, SJ ;
COATES, WJ ;
COMER, MB ;
REEVES, ML ;
WARRINGTON, BH .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 1990, 25 (09) :765-774
[2]   Novel platelet inhibitors [J].
Bennett, JS .
ANNUAL REVIEW OF MEDICINE, 2001, 52 :161-184
[3]   α1-adrenoceptor antagonists.: 6.: structural optimization of pyridazinone-arylpiperazines.: Study of the influence on affinity and selectivity of cyclic substituents at the pyridazinone ring and alkoxy groups at the arylpiperazine moiety [J].
Betti, L ;
Corelli, F ;
Floridi, M ;
Giannaccini, G ;
Maccari, L ;
Manetti, F ;
Strappaghetti, G ;
Botta, M .
JOURNAL OF MEDICINAL CHEMISTRY, 2003, 46 (16) :3555-3558
[4]   AMINO-ACIDS AND PEPTIDES .16. CHARACTERISATION OF MONAMYCINS, MEMBERS OF A NEW FAMILY OF CYCLODEPSIPEPTIDE ANTIBIOTICS [J].
BEVAN, K ;
DAVIES, JS ;
HASSALL, CH ;
MORTON, RB ;
PHILLIPS, DA .
JOURNAL OF THE CHEMICAL SOCIETY C-ORGANIC, 1971, (03) :514-&
[5]   AGGREGATION OF BLOOD PLATELETS BY ADENOSINE DIPHOSPHATE AND ITS REVERSAL [J].
BORN, GVR .
NATURE, 1962, 194 (4832) :927-&
[6]   CARDIOTONIC AGENTS .1. 4,5-DIHYDRO-6-[4-(1H-IMIDAZOL-1-YL)PHENYL]-3(2H)-PYRIDAZINONES - NOVEL POSITIVE INOTROPIC AGENTS FOR THE TREATMENT OF CONGESTIVE HEART-FAILURE [J].
BRISTOL, JA ;
SIRCAR, I ;
MOOS, WH ;
EVANS, DB ;
WEISHAAR, RE .
JOURNAL OF MEDICINAL CHEMISTRY, 1984, 27 (09) :1099-1101
[7]   Pharmacological control of platelet function [J].
Clutton, P ;
Folts, JD ;
Freedman, JE .
PHARMACOLOGICAL RESEARCH, 2001, 44 (04) :255-264
[8]   1,4-BIS(3-OXO-2,3-DIHYDROPYRIDAZIN-6-YL)BENZENE ANALOGS - POTENT PHOSPHODIESTERASE INHIBITORS AND INODILATORS [J].
COATES, WJ ;
PRAIN, HD ;
REEVES, ML ;
WARRINGTON, BH .
JOURNAL OF MEDICINAL CHEMISTRY, 1990, 33 (06) :1735-1741
[9]   Pyridazine derivatives.: Part 39:: Reactivity of 5-iodopyridazin-3(2H)-ones in palladium-catalysed reactions [J].
Coelho, A ;
Sotelo, E ;
Novoa, H ;
Peeters, OM ;
Blaton, N ;
Raviña, E .
TETRAHEDRON, 2004, 60 (52) :12177-12189
[10]   NEW PYRIDAZINONE DERIVATIVES AS INHIBITORS OF PLATELET-AGGREGATION [J].
CORSANO, S ;
VEZZA, R ;
SCAPICCHI, R ;
FORESI, S ;
STRAPPAGHETTI, G ;
NENCI, GG ;
GRESELE, P .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 1995, 30 (7-8) :627-631